Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells

被引:113
作者
Minko, T
Kopecková, P
Kopecek, J [1 ]
机构
[1] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA
关键词
adriamycin; doxorubicin; HPMA copolymer; apoptosis; multidrug resistance; gene expression; signal transduction;
D O I
10.1023/A:1018959029186
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To study peculiarities and the mechanism of the anticancer effect of free and HPMA copolymer-bound ADR in sensitive and resistant human ovarian carcinoma cells. Methods. Sensitive A2780 and ADR resistant A2780/AD cells were exposed to different doses of drugs during 12, 24, 36, 48, 60, and 72 hours. Cell viability, drug accumulation, apoptosis, cellular metabolism, lipid peroxidation, DNA content and gene expression were studied. Results. HPMA copolymer-bound ADR (P(GFLG)-ADR) possessed a comparable cytotoxicity to free ADR when comparison was based on intracellular concentrations. While free ADR up-regulated genes encoding ATP driven efflux pumps (MDR1, MRP), P(GFLG)-ADR overcame existing pumps and down regulated the MRP gene. Free ADR also activated cell metabolism and expression of genes responsible for detoxification and DNA repair. P(GFLG)-ADR down-regulated HSP70, GST-pi, BUDP, Topo-II alpha, beta, and TK-1 genes. Apoptosis, lipid peroxidation and DNA damage were significantly higher after exposure to P(GFLG)-ADR, as reflected by simultaneous activation of p53, cfos in A2780 cells) or c-jun (A2780/AD) signaling pathways and inhibition of the bcl-2 gene. Differences between free ADR and P(GFLG)-ADR increased with the time of incubation and drug concentration. Conclusions. P(GFLG)-ADR overcame drug efflux pumps, more significantly induced apoptosis and lipid peroxidation, inhibited DNA repair, replication, and biosynthesis when compared to free ADR.
引用
收藏
页码:986 / 996
页数:11
相关论文
共 31 条
[1]  
[Anonymous], ADV POLYM SCI
[2]   Apoptosis: A new pharmacodynamic endpoint [J].
Au, JLS ;
Panchal, N ;
Li, D ;
Gan, YB .
PHARMACEUTICAL RESEARCH, 1997, 14 (12) :1659-1671
[3]   RAPID COLORIMETRIC ASSAY FOR CELL-GROWTH AND SURVIVAL - MODIFICATIONS TO THE TETRAZOLIUM DYE PROCEDURE GIVING IMPROVED SENSITIVITY AND RELIABILITY [J].
DENIZOT, F ;
LANG, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 89 (02) :271-277
[4]   P-glycoprotein - A mediator of multidrug resistance in tumour cells [J].
Germann, UA .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) :927-944
[5]   RE-EXAMINATION AND FURTHER DEVELOPMENT OF A PRECISE AND RAPID DYE METHOD FOR MEASURING CELL-GROWTH CELL KILL [J].
HANSEN, MB ;
NIELSEN, SE ;
BERG, K .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 119 (02) :203-210
[6]   MECHANISMS OF MULTIDRUG RESISTANCE IN CANCER-TREATMENT [J].
HARRIS, AL ;
HOCHHAUSER, D .
ACTA ONCOLOGICA, 1992, 31 (02) :205-213
[7]   Expression of multidrug resistance-related genes (mdrl, MRP, GST-pi and DNA topoisomerase II) in urothelial cancers [J].
Kim, WJ ;
Kakehi, Y ;
Wu, WJ ;
Fukumoto, M ;
Yoshida, O .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (03) :361-368
[8]  
Kool M, 1997, CANCER RES, V57, P3537
[9]  
Kopecek J., 1991, US Patent, Patent No. [5 037 883, 5037883]
[10]  
KRISHNAMACHARY N, 1993, CANCER RES, V53, P3658